TERAPEUTIC EFFECTS OF MIGRAINE WITH CANNABIS TREATMENT
DOI:
https://doi.org/10.36557/2674-8169.2024v6n3p2242-2249Keywords:
Migraine, Treatment, Cannabis, Effectiveness, ParacetamolAbstract
In this article, was conducted a literature review on the use of Cannabis for the treatment of migraines in which 28 articles were analyzed, including case studies, cross-sectional studies, clinical trials, among others. Migraine is a very disabling chronic disease that affects around 15% of the world’s population. Different medications are used in the treatment of migraines, and since cannabis use in many diseases is increasing, it is interesting to consider its use in migraines too. The results highlight the importance of observing if the treatment is actually helping, and being sure that it is not causing any damage or making it worse. The conclusion was that the use of cannabis in the treatment of migraine in some studies was effective, while others considered that it was not, concluding that more studies are still needed to analyze the risk, benefit and effectiveness of this method of treatment.
Downloads
References
AVIRAM, Joshua et al. Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional Study. Brain Sciences, v. 10, n. 6, p. 360, 9 jun. 2020. Disponível em: https://doi.org/10.3390/brainsci10060360. Acesso em: 22 mar. 2024.
BARON, Eric P. et al. Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort. The Journal of Headache and Pain, v. 19, n. 1, 24 maio 2018. Disponível em: https://doi.org/10.1186/s10194-018-0862-2. Acesso em: 22 mar. 2024.
BRODIE, Martin J. et al. A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures. Cannabis and Cannabinoid Research, 15 fev. 2021. Disponível em: https://doi.org/10.1089/can.2020.0075. Acesso em: 22 mar. 2024.
CUTTLER, Carrie et al. Short- and Long-Term Effects of Cannabis on Headache and Migraine. The Journal of Pain, v. 21, n. 5-6, p. 722-730, maio 2020. Disponível em: https://doi.org/10.1016/j.jpain.2019.11.001. Acesso em: 22 mar. 2024.
DODICK, David W. Migraine. The Lancet, v. 391, n. 10127, p. 1315-1330, mar. 2018. Disponível em: https://doi.org/10.1016/s0140-6736(18)30478-1. Acesso em: 22 mar. 2024.
GIBSON, Laurel P. et al. Experience of migraine, its severity, and perceived efficacy of treatments among cannabis users. Complementary Therapies in Medicine, v. 56, p. 102619, jan. 2021. Disponível em: https://doi.org/10.1016/j.ctim.2020.102619. Acesso em: 22 mar. 2024.
J”ÈWIAK-B BENISTA, MARTA; Z. NOWAK, JERZY. PARACETAMOL: MECHANISM OF ACTION, APPLICATIONS AND SAFETY CONCERN. Acta Poloniae Pharmaceutica-Drug Research, v. 71, n. 1, p. 1-13, 23 nov. 2014. Disponível em: https://www.ptfarm.pl/pub/File/Acta_Poloniae/2014/1/011.pdf. Acesso em: 21 mar. 2024.
KVAMME, Sinikka L. et al. Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample. Harm Reduction Journal, v. 18, n. 1, 10 jul. 2021. Disponível em: https://doi.org/10.1186/s12954-021-00520-5. Acesso em: 22 mar. 2024.
LARSON, Anne M. et al. Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study. Hepatology, v. 42, n. 6, p. 1364-1372, 2005. Disponível em: https://doi.org/10.1002/hep.20948. Acesso em: 22 mar. 2024.
MARTÍN-SÁNCHEZ, Eva et al. Systematic Review and Meta-analysis of Cannabis Treatment for Chronic Pain. Pain Medicine, v. 10, n. 8, p. 1353-1368, nov. 2009. Disponível em: https://doi.org/10.1111/j.1526-4637.2009.00703.x. Acesso em: 22 mar. 2024.
ORGANIZAÇÃO MUNDIAL DA SAÚDE. Atlas of Headache Disorders and Resources in the World 2011: Organização Mundial da Saúde, 2011. ISBN: 9789241564212
PARACETAMOL: Solução oral (gotas) 200 mg/ml. Farmacêutica Responsável: Gabriela Mallmann. Guarulhos – SP: Aché Laboratórios Farmacêuticos S.A. 1 bula de remédio. p.2-6. Disponível em: file:///C:/Users/125111378599/Downloads/bula_1684957528001.pdf. Acesso em: 24 maio. 2023.
SECRETARIA DE ESTADO DE SAÚDE DE GOIÁS. Enxaqueca. Secretaria de estado de saúde de Goiás, Goiás, p.1, novembro. 2019.
STEINER, Timothy J. et al. Migraine is first cause of disability in under 50s: will health politicians now take notice? The Journal of Headache and Pain, v. 19, n. 1, 21 fev. 2018. Disponível em: https://doi.org/10.1186/s10194-018-0846-2. Acesso em: 22 mar. 2024.
STITH, Sarah S. et al. Alleviative effects of Cannabis flower on migraine and headache. Journal of Integrative Medicine, v. 18, n. 5, p. 416-424, set. 2020. Disponível em: https://doi.org/10.1016/j.joim.2020.07.004. Acesso em: 22 mar. 2024.
WARE, Mark A. et al. Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS). The Journal of Pain, v. 16, n. 12, p. 1233-1242, dez. 2015. Disponível em: https://doi.org/10.1016/j.jpain.2015.07.014. Acesso em: 22 mar. 2024.
ZHANG, Niushen; WOLDEAMANUEL, Yohannes W. Medication overuse headache in patients with chronic migraine using cannabis: A case–referent study. Headache: The Journal of Head and Face Pain, v. 61, n. 8, p. 1234-1244, 9 ago. 2021. Disponível em: https://doi.org/10.1111/head.14195. Acesso em: 22 mar. 2024.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Larissa Helena Sacheto Abdo, Mariana Lima de Moura
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are copyright holders under a CCBY 4.0 license.
